These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11983016)

  • 41. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
    Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
    Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
    Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
    Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Justification of specific genetic modifications in pigs for clinical organ xenotransplantation.
    Cooper DKC; Hara H; Iwase H; Yamamoto T; Li Q; Ezzelarab M; Federzoni E; Dandro A; Ayares D
    Xenotransplantation; 2019 Jul; 26(4):e12516. PubMed ID: 30989742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of Formosan macaques.
    Tu CF; Tai HC; Wu CP; Ho LL; Lin YJ; Hwang CS; Yang TS; Lee JM; Tseng YL; Huang CC; Weng CN; Lee PH
    Transplant Proc; 2010; 42(6):2138-41. PubMed ID: 20692427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.
    Costa C; Zhao L; Burton WV; Rosas C; Bondioli KR; Williams BL; Hoagland TA; Dalmasso AP; Fodor WL
    Xenotransplantation; 2002 Jan; 9(1):45-57. PubMed ID: 12005104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
    Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
    Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts.
    Quan D; Bravery C; Chavez G; Richards A; Cruz G; Copeman L; Atkinson C; Holmes B; Davies H; Cozzi E; White D
    Transplant Proc; 2000 Aug; 32(5):936-7. PubMed ID: 10936282
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion--immunopathological findings.
    Pascher A; Poehlein C; Storck M; Abendroth D; Mueller-Hoecker J; Koenig W; Young VK; White DJ; Hammer C
    Transpl Int; 1996; 9 Suppl 1():S385-7. PubMed ID: 8959869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of human ABO blood groups on human xenoreactive antibody-mediated cytotoxicity and the protective effect of human decay-accelerating factors exogene on swine endothelium.
    Lee JM; Tu CF; Tai HC; Chou NK; Weng CN; Lee YC; Lee PH
    Transplant Proc; 2008 Mar; 40(2):551-3. PubMed ID: 18374126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons.
    Ghanekar A; Lajoie G; Luo Y; Yang H; Choi J; Garcia B; Greig PD; Cattral MS; Cole EH; Phillips MJ; Cardella CJ; Levy GA; Zhong R; Grant DR
    Transplant Proc; 2001; 33(7-8):3849-50. PubMed ID: 11750638
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
    Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical xenotransplantion--how close are we?
    Cooper DK
    Lancet; 2003 Aug; 362(9383):557-9. PubMed ID: 12932390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of human DAF, CD59, MCP transgene in xenotransplantation.
    Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
    Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Transgenic swine as potential organ donors? Results of the ex-vivo hemoperfusion hDAF transgenic kidney with human blood].
    Storck M; Abendroth D; White DJ; Pino-Chavez G; Fakler JA; Hammer C
    Zentralbl Chir; 1998; 123(7):785-92. PubMed ID: 9746976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation.
    Lavitrano M; Bacci ML; Forni M; Lazzereschi D; Di Stefano C; Fioretti D; Giancotti P; Marfé G; Pucci L; Renzi L; Wang H; Stoppacciaro A; Stassi G; Sargiacomo M; Sinibaldi P; Turchi V; Giovannoni R; Della Casa G; Seren E; Rossi G
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14230-5. PubMed ID: 12393815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of transgene integration sites in transgenic pigs by fluorescence in situ hybridization.
    Kuipers HW; Langford GA; White DJ
    Transgenic Res; 1997 Jul; 6(4):253-9. PubMed ID: 9232026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.